ESPOSITO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 6.328
AS - Asia 4.165
EU - Europa 2.031
SA - Sud America 277
AF - Africa 28
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.835
Nazione #
US - Stati Uniti d'America 6.235
HK - Hong Kong 2.162
SG - Singapore 772
CN - Cina 714
IT - Italia 510
UA - Ucraina 493
VN - Vietnam 267
DE - Germania 262
BR - Brasile 248
RU - Federazione Russa 219
FI - Finlandia 156
IE - Irlanda 139
TR - Turchia 79
SE - Svezia 75
FR - Francia 48
GB - Regno Unito 48
KR - Corea 45
MX - Messico 44
CA - Canada 38
IN - India 38
PL - Polonia 17
JP - Giappone 15
BD - Bangladesh 14
ZA - Sudafrica 14
AR - Argentina 13
CZ - Repubblica Ceca 13
IQ - Iraq 12
ES - Italia 11
PK - Pakistan 7
AT - Austria 6
IL - Israele 6
ID - Indonesia 5
LT - Lituania 5
PH - Filippine 5
CL - Cile 4
CO - Colombia 4
JO - Giordania 4
MA - Marocco 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
NL - Olanda 3
RO - Romania 3
UZ - Uzbekistan 3
VE - Venezuela 3
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
EC - Ecuador 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
Totale 12.835
Città #
Hong Kong 2.160
Ann Arbor 1.338
Wilmington 691
Chandler 619
Jacksonville 596
Dallas 510
Princeton 393
Singapore 300
Houston 263
Ashburn 236
Dong Ket 210
Woodbridge 209
Beijing 145
Munich 139
Dublin 136
Boardman 111
Nanjing 110
Dearborn 107
Andover 97
Pellezzano 76
Salerno 65
Izmir 62
Mestre 49
Moscow 49
Los Angeles 46
Fairfield 41
Helsinki 41
Redwood City 37
Nanchang 35
Hebei 33
Shenyang 33
Changsha 27
New York 25
São Paulo 25
Ho Chi Minh City 22
Tianjin 21
Jiaxing 20
Pune 19
Montreal 17
Warsaw 17
Napoli 16
Sant'agata De' Goti 16
Tokyo 15
Washington 15
Cuauhtémoc 14
Santa Clara 14
Agropoli 13
Brno 12
Brooklyn 12
Norwalk 12
Phoenix 12
Turku 12
Belo Horizonte 11
Cava 11
Düsseldorf 11
Ottawa 11
San Diego 11
Seattle 11
Stockholm 11
Guangzhou 10
Johannesburg 10
London 10
Istanbul 9
Lessolo 9
Boston 8
Chicago 8
Hanoi 8
Naples 8
Poplar 8
Potenza 8
Rio de Janeiro 8
Spinea 8
The Dalles 8
Bari 7
Bologna 7
Caserta 7
Chennai 7
Council Bluffs 7
Jinan 7
Manchester 7
Kunming 6
Marsico Nuovo 6
Mexico City 6
Shanghai 6
Atlanta 5
Charlotte 5
Curitiba 5
Denver 5
Hefei 5
Portici 5
Querétaro 5
San Francisco 5
Springfield 5
Vienna 5
Amman 4
Ankara 4
Belgrade 4
Brasília 4
Cambridge 4
Columbus 4
Totale 9.637
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 698
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 628
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 544
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 311
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 257
Searching for the protein targets of 4-nonylphenol using a computational approach 241
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 222
Analysis of transglutaminase protein substrates by functional proteomics. 205
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 180
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 169
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 169
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 167
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 164
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 163
Application of a computational approach to identify protein targets for 4-nonylphenol 153
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 151
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 146
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 140
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 139
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 138
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 136
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 136
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 136
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 134
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 134
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 131
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 130
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 130
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 129
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 128
Tissue transglutaminase in celiac disease: role of autoantibodies. 128
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 123
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 118
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 114
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 114
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 113
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 111
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 111
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 111
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 110
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 110
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 109
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 108
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 107
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 106
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 105
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 101
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 101
Transglutaminase 2 in celiac diasease: Minireview article 100
Tissue Transglutaminase and Coeliac Disease. 99
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 99
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 99
null 98
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 96
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 96
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 96
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 95
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 95
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 94
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 91
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 91
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 91
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 88
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 88
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 88
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 87
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 85
Effects of Methyl Bromide on activity of blood coagulation enzymes 85
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 83
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 83
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 83
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 81
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 80
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 80
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 78
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 77
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 77
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 76
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 75
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 75
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 75
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 75
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 74
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 73
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 73
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 72
null 71
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 71
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 71
The mechanism of cytotoxicity of 4-nonylphenol in a human hepatic cell line involves ER-stress, apoptosis, and mitochondrial dysfunction 71
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 69
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 69
Desmoplakin acts as transglutaminase substrate in vitro. 68
null 67
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 66
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 66
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 65
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 64
Coeliac disease and extraintestinal autoimmunity. 63
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 63
Totale 12.504
Categoria #
all - tutte 40.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021772 0 0 0 0 132 37 112 9 132 13 115 222
2021/2022769 0 0 4 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/20263.853 540 980 1.501 330 502 0 0 0 0 0 0 0
Totale 13.045